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ABSTRACT
Besides their commonly attributed role in the main-
tenance of low-copy number plasmids, toxin/anti-
toxin (TA) loci, also called ‘addiction modules’,
have been found in chromosomes and associated
to a number of biological functions such as: reduc-
tion of protein synthesis, gene regulation and
retardation of cell growth under nutritional stress.
The recent discovery of TA loci in obligatory intracel-
lular species of the Rickettsia genus has prompted
new research to establish whether they work as
stress response elements or as addiction systems
that might be toxic for the host cell. VapBC2 is a
TA locus from R. felis, a pathogen responsible for
flea-borne spotted fever in humans. The VapC2
toxin is a PIN-domain protein, whereas the antitoxin,
VapB2, belongs to the family of swapped-hairpin
b-barrel DNA-binding proteins. We have used a com-
bination of biophysical and structural methods to
characterize this new toxin/antitoxin pair. Our
results show how VapB2 can block the VapC2
toxin. They provide a first structural description of
the interaction between a swapped-hairpin b-barrel
protein and DNA. Finally, these results suggest how
the VapC2/VapB2 molar ratio can control the
self-regulation of the TA locus transcription.
INTRODUCTION
Toxin–antitoxin (TA) complexes were ﬁrst discovered as
factors that protect low-copy number plasmids in bacteria
from segregation loss (1). One protein in the pair is toxic
to the cell and stable, whereas its corresponding antitoxin
is unstable and requires continuous transcription to re-
versibly inhibit the toxin by engaging in a non-covalent
complex. If the plasmid is not correctly segregated during
cell division, one of the daughter cells will not carry the
plasmid but will still have a number of copies of the TA
complex. Eventually, the labile antitoxin will be degraded
by proteases while the stable toxin will persist and kill
the plasmid-free cell. In this way, the presence of TA
loci prevents the proliferation of plasmid-free cells in
growing bacterial cultures, and for that reason TA
systems have been described as ‘addiction modules’.
More recently, TA loci have been associated to other bio-
logical functions such as attenuation of protein synthesis
and retardation of cell growth under conditions of nutri-
tional stress (2–4). In this regard, TA would play a role in
stress physiology rather than in bacterial programmed cell
death.
The most common activity of TA toxins seems to be
that of an mRNA-speciﬁc endonuclease. Such activity
has been already conﬁrmed for RelE and MazF (5).
VapC toxins from enteric bacteria have recently shown
to speciﬁcally cleave initiator tRNA
fMet (4). Nevertheless,
two other activities have been reported: CcdB and ParE
are inhibitors of DNA gyrase and the recently
characterized HipA toxin is a protein kinase (6). In turn,
the antitoxins consist of two domains, a C0-terminal
one involved in protein–protein interactions and an
N0-terminal domain responsible for DNA-binding (7,8).
They belong to one of several different classes of DNA
binding proteins. The binding to the toxin and to the
DNA stabilizes the antitoxin, which otherwise exhibits a
largely disordered structure highly susceptible to proteoly-
sis. However, the main function of the TA binding to
DNA is related to transcriptional control; TA operons
are all self-regulated at the transcription level by the anti-
toxins, which bind to the TA operon promoters. In this
respect, the toxin components can be considered as
corepressors of their own transcription because TA
complexes bind to DNA more strongly than antitoxins
alone.
TA pairs have been classiﬁed into families based on the
toxin structural features and mode of action (9). One of
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is deﬁned by the presence of a PIN-domain protein as
the toxic component (VapC). The PIN domain
(PFAM: PF01850) was ﬁrst annotated on the basis of
sequence similarity to the N0-terminal domain of the
type IV pili protein, pilT, from Myxococcus xanthus
(PIN, PilT N0-terminus). In prokaryotes the majority of
PIN-domain proteins are the toxic components of
chromosomally encoded TAs. PIN-domain proteins
exhibit structural homology to the T4 RNase H nuclease
domain (10). Actually, the PIN-domain of the yeast Dis3
protein and the VapC toxin from enteric bacteria bear
endoribonuclease activity (4,11), supporting the notion
of a ribonuclease function for other PIN-domain toxins.
Although sequence similarity is low within the
PIN-domain, multiple-sequence alignments have shown
that active site residues are highly conserved.
Other TA systems extensively studied include
Escherichia coli MazEF and archaeal RelBE. The MazF
toxin cleaves mRNA speciﬁcally at ACA sequences. The
crystal structure of the MazEF complex shows a
heterohexameric organization with a MazE dimer sand-
wiched between two MazF dimers (12). The interaction
between MazE and MazF is mediated by the ﬂexible
C0-terminus of the antitoxin that wraps around the toxin
homodimer. The RelE toxin is a global inhibitor of trans-
lation that is activated by nutritional stress to cleave
mRNA positioned at the ribosomal A-site (13,14).
RelB inhibits the action of RelE by wrapping around
the toxin, thus preventing it from binding to the ribosomal
A-site (15).
It is worth to note that a particular type of toxins can
form TA systems with antitoxins from different protein
super-families (16). Thus, the RelE/ParE toxins have
been found associated with antitoxin transcriptional
factors belonging to the MetJ/Arc, the PhD/YefM or
the cHTH super-families. Likewise, sequence analyses
have identiﬁed several PIN-domain toxins immediately
adjacent to genes encoding homologues of transcriptional
regulators belonging to at least four different classes,
namely HTH, RHH, Phd/YefM and AbrB. These obser-
vations might indicate that TA loci have evolved through
gene shufﬂing or partner switching (9,16).
Most of the structures of TA complexes reported so
far comprise only the toxin and the C0-terminal domain
of the antitoxin that wraps around it. Thus, very little
structural information has been obtained concerning the
N0-terminal DNA binding domain of antitoxins. The case
of MazEF is an exception (12). The structure of the
MazEF heterohexamer has shown that the antitoxin
MazE homodimer contains an N0-terminal, intertwined
b-barrel. This structure classiﬁes MazE as a member of
the large super-family of DNA binding proteins repre-
sented by the N0-terminal domain of the transcriptional
factor AbrB (12, 17). Proteins from this family consist of
four b-strands arranged in two anti-parallel hairpins that
are interleaved in the dimer, justifying the name given to
their fold: swapped-hairpin barrel.
Two crystal structures of a promoter-bound TA
complex have been reported, namely those of FitAB
from Neisseria gonorrhoeae, bound to a 36-bp DNA
fragment from the ﬁtAB promoter (7) and of E. coli
HipAB, bound to a 21-bp operator DNA (18). The anti-
toxin FitA contains an N0-terminal domain with a DNA
binding ribbon–helix–helix (RHH) motif, and a
C0-terminal extended domain including an a-helix that
interacts with the PIN-domain of the FitB toxin. Four
FitA and four FitB molecules form a tetramer of
heterodimers that explains why the binding to the toxin
enhances the antitoxin afﬁnity for the DNA. This struc-
ture also explains why the presence of the toxin and DNA
partners stabilize the inherently ﬂexible structure of the
antitoxin. In turn, HipAB bind to DNA as a dimer of
heterodimers, which also results in an enhanced DNA
recognition with respect to the binding of the antitoxin
alone (19).
Although well known in plasmids and in the chromo-
somes of free-living bacteria and archaea, the presence of
TA loci was only recently conﬁrmed in obligatory intra-
cellular species. Thus, the complete genome sequence of
Rickettsia felis, a ﬂea-borne pathogen responsible for
spotted fever in humans (20,21), has revealed the
presence of at least 13 TA loci (22). The Rickettsia TA
loci are presumed to work as addiction systems, where
the elimination of TA-containing Rickettsia from host
cells could lead to the release of the toxin in the cyto-
plasm of host, which would result in cell death (23).
One of the R. felis TA loci includes VapC2, a protein
that exhibits in vitro RNase activity and that can inhibit
the growth of transformed E. coli and S. cerevisiae
cultures (23).
We present here evidence, from multi-angle light scat-
tering and refractometry data, for the existence of two
types of R. felis VapBC2 complexes and reveal the struc-
ture of one of them, the octameric VapBC2 complex
bound to a 27-bp dsDNA fragment from its own
promoter. As in the case of FitAB, four toxins and four
antitoxins form a tetramer of heterodimers that bind to
the dsDNA. The toxin VapC2 contains a PIN-domain
that forms homodimers homologous to those of FitB.
However, the DNA-binding domain of the VapB2 anti-
toxin does not fold as the RHH domain of FitA. Instead,
VapB2 forms homodimers that display a swapped-hairpin
b-barrel fold, similar to MazE, thus illustrating the rich
interplay between toxin and antitoxin super-families.
Hence, this is the ﬁrst structure of a TA pair composed
of a toxin belonging to the VapC family and an antitoxin
belonging to the AbrB/MazE superfamily. It is also the
ﬁrst experimental structure showing the complex of a
swapped-hairpin b-barrel protein with a DNA fragment.
We discuss how these data help to understand the inter-
play between the toxin inhibition and transcription repres-
sion functions of the antitoxin protein.
MATERIALS AND METHODS
Protein production
For expression in E. coli, R. felis vapB2 and vapC2 were
cloned in operon using the Gateway (Life Technologies,
Carlsbad, CA, USA) compatible destination vector
pETG20A, where VapB2 was fused to thioredoxin
3246 Nucleic Acids Research, 2012,Vol.40, No. 7(TRX) at its N0-terminus to improve protein expression
and solubility (24). TRX was His-tagged and followed by
the tobacco virus (TEV) protease cleavage sequence,
which respectively allowed afﬁnity puriﬁcation and
release of the target protein.
The VapBC2 complex was expressed in BL21 Rosetta
(DE3) pLysS cells (Novagen). Bacteria were grown at
37 C in auto-inducing media (25) for 4h and
transferred to 17 C when OD600nm reached  2 (24). The
selenomethionine-labelled protein was also produced
using autoinducing media (25). Cultures were harvested
by centrifugation at 4000g during 10min and frozen at
 80 C. The cell pellet was resuspended in a buffer con-
taining 300mM NaCl, 50mM Tris–HCl pH 8.0, 0.25mg/
ml lysozyme, 10mM imidazole, 20mg/ml DNaseI, 20mM
MgSO4 and a cocktail of protease inhibitors (Complete
EDTA-free, Roche). Cells were disrupted by sonication
and the lysate clariﬁed by centrifugation at 20000g for
30min at 4 C.
The TA complex was loaded on a Ni
2+-afﬁnity chroma-
tography, HisTrap column (GE Healthcare) and eluted in
a buffer containing 300mM NaCl, 50mM Tris–HCl pH
8.0 and 250mM imidazole. After this ﬁrst puriﬁcation step
the His-tagged thioredoxin fusion was cleaved by the
addition of TEV protease. The TA complex was then
recovered in the ﬂow-through of a second Ni
2+-afﬁnity
chromatography.
Oligonucleotides for crystallization were annealed by
slow cooling in a buffer containing 20mM Tris–HCl
(pH 8.0) and 150mM NaCl. The sequence of the
forward oligonucleotide was 50-TTAATATATACTAAT
TAATATATACTA-30. The VapBC2 complex was mixed
with the duplex DNA in a 4:1 molar ratio and puriﬁed by
gel ﬁltration in a preparative Superdex 75 HR16/60
column, using a buffer containing 25mM Tris–HCl pH
8.0 and 150mM NaCl.
The purity of the sample was veriﬁed by SDS–poly-
acrylamide gel electrophoresis on NuPAGE Bis-Tris
gels (Invitrogen).
Multiangle light scattering
The molecular weight was calculated using analytical
size-exclusion chromatography (SEC) on a high-
performance liquid chromatography (HPLC) system
(Waters) coupled with online multiangle laser light scat-
tering, ultra-violet light absorbance and refractive index
detectors (MALLS/UV/RI) (Wyatt Technology, Santa
Barbara, CA, USA). SEC was performed on a Shodex
KW-804 column with 25mM HEPES pH 7.5, 150mM
NaCl as the eluent. The molecular weight was calculated
using ASTRA V software (Wyatt Technology) with a re-
fractive index increment (dn/dc) of 0.185ml/g for protein
samples. In the ‘protein conjugate’ analysis of VapBC2–
DNA complexes we used extinction coefﬁcients, at
280nm, of 0.95ml/(mg cm) and 14.31ml/(mg cm)
for VapBC2 and for the DNA, respectively. In this
analysis, the refractive index increment of DNA was set
to 0.166ml/g (26).
Surface plasmon resonance
A Biacore 1000 surface plasmon resonance system was
used to study the direct binding of the VapBC2 complex to
its putative cognate DNAs, as predicted from sequence
analysis of the TA locus. Two different 55-mer DNA frag-
ments, with sequences:
vapBC2_A: 50-ATATTTAGAATAGTTGTTTGCTTTA
ATAATAAAGTTAATATATACTAATT-30
vapBC2_B: 50-AGTTGTTTGCTTTAATAATAAAGTT
AATATATACTAATTAATATATACTA-3 0
were individually immobilized (332 and 268 resonance
units (RU), respectively) on research grade streptavidin
(SA) sensor chips. Puriﬁed VapBC2 in Tris buffer
[50mM Tris–HCl (pH 8.0), 150mM NaCl, and 0.005%
(v/v) Tween-20] was then injected at concentrations
ranging from 0.25mMt o9 mM over the immobilized
DNAs at 25 C at a ﬂow rate of 20ml/min. Dissociation
constants (KD) were derived by non-linear curve ﬁtting of
the standard Langmuir binding isotherm using the signal
at the equilibrium response level with the BIAevaluation
software (version 4.1).
Complex crystallization
The VapBC2 complex bound to the 27-bp dsDNA was
concentrated to 6mg/ml. Crystals were obtained by the
vapour diffusion method using a nanodrop-dispensing
robot (Honeybee 961; Cartesian) in 96-well Greiner crys-
tallization plates. The drops contained 300nl of the
complex and 100nl of the crystallization agent, a
solution of 12% PEG4000, 4% PEG400, and 100mM
MES pH 6.5. Subsequent optimizations were manually
performed in 24-well plates. Crystals were very fragile,
therefore cryoprotection was achieved by gradually
increasing the concentration of PEG400 to 12%. The
crystals were then ﬂash-cooled in liquid nitrogen.
Crystals belonged to the space group P212121 with unit
cell parameters a=80.8A ˚ , b=92.3A ˚ , whereas c was
found to vary from crystal to crystal in the range of
143–164A ˚ . A Matthew’s coefﬁcient of 2.62, corresponding
to a solvent content of 58.2%, was found to be compatible
with the presence in the asymmetric unit of four TA
homodimers and one molecule of double stranded DNA.
Crystal structure determination and reﬁnement
Data were collected at the European Synchrotron
Radiation Facility, ESRF (Grenoble, France). A single-
wavelength anomalous diffraction (SAD) data set was col-
lected at the Selenium peak wavelength (l=0.9785A ˚ )a t
beamline ID14eh4. Besides, two native data sets, from two
different crystals, diffracting to 2.5 and 2.85A ˚ resolution
were collected at beamlines ID14eh1 and ID23eh2,
respectively. All data sets were reduced using XDS (27)
and SCALA (28) (Table 1). The structure of the complex
was solved by the SIRAS (Single Isomorphous Replace-
ment with Anomalous Signal) method. Substructure
determination, phase calculation, and density modiﬁca-
tion were carried out with autoSHARP (29) and
SOLOMON (30). Phases provided by SOLOMON were
Nucleic Acids Research,2012, Vol.40, No. 7 3247introduced in BUCANEER to build an initial model of
the protein components of the asymmetric unit. The rest
of the model was manually built using COOT (31). The
model was reﬁned against the native data set with
autoBUSTER (32) using TLS (translation/libration/
screw) parameters, with one TLS group per chain. The
ﬁnal Rfree is 22% and Rcryst is 17% (Table 1). Model val-
idation was done with Molprobity (33). PISA (34) was
used for the analysis of interfaces. Electrostatic calcula-
tions were carried out with the program APBS (35), and
the electrostatic potential distribution was represented
using Chimera (36), which was also used to prepare
ﬁgures.
Structure deposition
Coordinates and structure factors for the DNA-bound
VapBC2 complex have been deposited in the PDB under
ID 3zvk.
RESULTS
The R. felis VapBC2 complex binds to its promoter DNA
TA complexes are known to repress the transcription of
their coding genes by binding to their promoter DNA. A
sequence analysis was carried out to identify possible
binding sites for R. felis VapBC2. We aimed at ﬁnding
sequence palindromes or repeats close to the TA
promoter, as found in other TA operator sites (37). This
analysis resulted in two possible binding sequences from
the VapBC2 locus promoter that we analysed by surface
plasmon resonance. One of them, vapBC2_B, displays
in vitro good afﬁnity with a KD of 0.11±0.004mM
(Figure 1a), whereas the other sequence, vapBC2_A,
shows a  40-fold higher KD of 4.15±0.76mM. A closer
inspection of the vapBC2_B sequence revealed that the 27
most downstream bases include a nearly perfect palin-
drome, a hallmark of TA operator sequences (37). There-
fore, we decided to pursue the rest of this study with this
shorter version of the VapBC2 operator sequence.
Rickettsiae felis VapBC2 forms octamers when bound to
its cognate DNA and hexamers in its absence
To gain insight into the stoichiometry of the complexes
made by VapB2, VapC2 and their cognate DNA, we
studied their oligomeric states by size exclusion chroma-
tography in conjunction with multiangle light scattering
(SEC/MALS). This technique allows the calculation,
from MALS data, of an average molecular weight for
macromolecules within each peak eluting from the SEC
column. We studied ﬁrst puriﬁed VapBC2 samples in the
absence of DNA. Our analyses show that VapBC2 forms
an 82.4kDa complex (Figure 1b). Given the molecular
masses of the VapC2 toxin (15.36kDa) and of the VapB2
antitoxin (9.01kDa), a number of TA ensembles are
Table 1. X-ray data and reﬁnement statistics
SeMet data set Native low resol Native high resol
ID14eh4 ID23eh2 ID14eh1
Data collection
Space group P212121 P212121 P212121
Cell dimensions (A ˚ , ) 81.5 92.9 163.4 82.0 92.8 164.1 80.8 92.3 150.5
Resolution (A ˚ )
a 49.0–3.5 (3.7–3.5) 49.2–2.9 (3.1–2.9) 47.3–2.5 (2.6–2.5)
No. observations
Measured 244369 115005 191495
Unique 16251 28411 39577
Completeness (%)
a 100 (98.8) 99.9 (99.9) 99.7 (99.7)
Rmeas (%)
a 10.9 (51.2) 9.6 (55.5) 6.6 (56.3)
Multiplicity
a 15.0 (15.4) 4.0 (4.1) 4.9 (4.8)
hhIi/s(hIi)i
a 23.2 (8.6) 10.9 (2.9) 17.4 (3.2)
Phasing power
Anomalous
b 0.935 (4.6A ˚ )
Isomorphous
b,c 0.565 (6.4A ˚ )
Reﬁnement and validation
Rcryst/Rfree (%)
d 17.23/21.72
No. atoms: protein/DNA/water 6431/1063/360
R.m.s.d.
e
Bonds/angles (A ˚ , ) 0.010/1.28
B factor (A ˚ 2) main/side chain 2.72/6.25
Ramachandran plot
f (# residues, %)
Favoured regions 764, 97.7
Allowed regions 781, 99.9
Outliers 1, 0.1
aValues in parentheses are for the highest resolution shell.
bValue in parenthesis: resolution for which phasing power drops below 1.0.
cIsomorphous phasing power for acentric reﬂections using native low resolution (ID23eh2) data set.
dRfree is Rcryst calculated for a test set of randomly selected 5% of the data.
eRoot mean standard deviation.
fRamachandran plot statistics as reported by Molprobity (33).
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Among them, complexes with 3:4 (total mass 82.12kDa)
and 4:2 (79.46kDa) stoichiometry are the likeliest ones,
given the relative amounts of the proteins as observed on
SDS acrylamide gels performed with the same samples.
Because both molecules belong to protein families known
to form homodimers, we consider the 4:2 complex as the
most probable one. We also note that this stoichiometry
coincides with that of the MazEF complex, which
includes an antitoxin of the same family than VapB2.
Then, based on the previously known complex of the
FitAB toxin with DNA, samples incubated at a 4:4:1
(VapB2:VapC2:DNA) molar ratio were also studied by
SEC/MALS. In this case, the analysis of the molecular
mass was carried out using the ‘‘protein conjugate’’
model, as implemented in the ASTRA software. In this
method, the combined use of light scattering, ultraviolet
and refractive index detectors enables the assessment of
the molar mass, size, and relative polymer fractions of a
copolymer such as a protein-DNA complex. With this
approach, a total mass of 111kDa breaks down
into 93.41 and 17.58 kDA for the protein and DNA
components, respectively (Figure 1c). These molar
masses are consistent with those expected for a 4:4:1
(VapB2:VapC2:DNA) complex, 97.48 and 17.17kDa,
respectively.
Overall structure of the R. felis VapBC2 complex bound
to its promoter DNA
We determined the structure of the VapBC2 TA com-
plex bound to a 27-bp double stranded DNA molecule
(Figure 2) by single isomorphous replacement with anom-
alous signal (SIRAS), using selenomethionine-substituted
proteins. The ﬁnal model, reﬁned to 2.5A ˚ , contains four
molecules of the toxin VapC2 (monomers A, B, C and D
encompassing residues 1–134 for the ﬁrst one and 1–133
for the other three), four molecules of the antitoxin VapB2
(monomers E, F, G and H comprising residues 2–58, 1–78,
2–77 and 1–57, respectively), 26 base pairs out of the 27
present in the double stranded DNA fragment used for
crystallization, 360 molecules of water and 4 molecules
of MES, the buffer used in the crystallization condition.
In a second native crystal, diffracting to 2.85A ˚ , all the
27-bp of the DNA fragments are visible. Whereas the
crystal packing contacts are slightly different (see
below), the conformation of the proteins and of the
DNA are largely the same than in the structure at 2.5A ˚ .
The quaternary structure of the complex can be con-
veniently described as a tetramer of VapBC2 heterodimers
bound to the DNA fragment (Figure 2a). In this regard,
this complex resembles that of FitAB bound to its
promoter. However, the VapBC2 complex is dramatically
more compact than that of FitAB. The heterodimers
Figure 1. Analysis of the complexes formed by the VapBC2 system in the absence and presence of their cognate DNA. (a) SPR sensorgrams
obtained by passing puriﬁed VapBC2 at the labelled concentrations (assuming an octamer) on the vapBC2_B DNA, annealed to its complement and
bound to a streptavidin sensor chip. The inset shows the steady-state analysis of the binding. (b) About 300mg of puriﬁed VapBC2 were subjected to
size-exclusion chromatography coupled to MALS/RI/UV detectors as described in the ‘Materials and Methods’ section. The molar mass (black line),
derived from refractive index measurements, and the absorption at 280nm (gray line) were plotted as a function of the elution time. (c) Same as in
(b) with 400mg of puriﬁed VapBC2 incubated with the dsDNA used for crystallization at a 4:1 molar ratio. For clarity, the graphs of derived molar
mass are only shown around the main absorption peak areas in (b) and (c). Molar mass values at the absorption peaks are indicated, with those
resulting from protein-conjugate analysis in parentheses.
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antitoxin–antitoxin dimerization interfaces. The whole
VapBC2 complex has a pseudo-dyad axis, perpendicular
to the DNA double helix (Figure 2). This pseudo-dyad
axis intersects the DNA at the A13/T15 base pair. The
interaction of the VapBC2 complex with the DNA is
mediated by the two antitoxin homodimers. The inter-
action with DNA is described in detail below.
Structure of the VapC2 toxin
VapC2 consists of 134 amino acids forming a compact
protein with an a/b/a fold. The topology of VapC2
includes 10 elements of secondary structure (Figure 3a),
namely b1 (residues 2 to 5), a1 (residues 7–16), a2
(residues 19–29), b2 (residues 33–37), a3 (residues 38–
50), a4 (residues 54–65), b3 (residues 69–71), a5
(residues 76–90), a6 (residues 99–109), b4 (residues 112–
115), b5 (residues 128–131). A central, twisted, parallel
b-sheet made of ﬁve strands (ordered 32145) is surrounded
by six a-helices, with four a-helices on one side of the sheet
and two on the other side. As predicted from sequence
alignments VapC2 folds as a PIN-domain. This assign-
ment was further conﬁrmed by a search for similar struc-
tures using the DALI server (38) that gave several
matches, all of them PIN-domain containing proteins.
The closest structural homologues are FitB
from Neisseria gonorrhoeae (7) (PDB: 2H1C, chain
A, Z-score=17.1), VapC2 (PDB ID: 3H87, chain A,
Z=15.1) and VapC-5 (39) (PDB ID: 3DBO, chain B,
Z=15.0) from Mycobaterium tuberculosis and two
archaeal proteins (PDB: 1Y82, Z=15.7; 1V96,
Z=15.3). PIN-domain proteins share two nearly invari-
ant aspartic acid residues and a conserved glutamic
amino-acid (40), which in VapC2 correspond to residues
Asp6, Asp99 and Glu43, respectively. During the cloning
a spontaneous mutation of Asp6 to glycine resulted in
VapC2, perhaps inhibiting its toxic effect and allowing
the overexpression of the protein.
Remarkably, VapC2 residues 116–123 (between strands
b4 and b5) form a coil where other PIN-domain proteins
bear a short helix, commonly described as helix a6. This
helix includes a less conserved acidic residue that resides in
the vicinity of the three well-conserved acidic amino acids
characteristic of the domain. In VapC2, Glu120 can be
regarded as the fourth acidic residue. In fact, the
electron density for residues 117–124 is weak and some
of them, or their side chains, could not be modelled.
Indeed, this part of the model slightly differs among the
four toxins. In monomers C and D this region is exposed
to the solvent, and thereby less well deﬁned than in
monomers A and B.
VapC2 forms nearly symmetric homodimers that bury a
solvent accessible surface area (SASA) of 1083±16A
2
per monomer, representing about 14% of the total
surface of the toxin (Figure 3b). The main contribu-
tions to the dimer interface arise from helices a3 and a5,
which cross-interact symmetrically, and from the loop
between strand b3 and helix a5. As in FitA, Phe73
(Phe78 in FitA) plays a crucial role in dimerization:
its backbone carbonyl and amine atoms establish
hydrogen bonds to the corresponding atoms in the
other monomer. Furthermore, the backbone carbonyl of
Phe73 also forms a hydrogen bond to Ser38 in the
other monomer. In the same loop, Asn72 from one
toxin hydrogen binds the backbone amine of Ala75 from
the neighbouring toxin. Finally, Tyr46 residues make a
stacking interaction with the aliphatic chains of Arg85.
Besides these contacts, interactions between
(a)( b)
(c)
VapB2
dimer
VapC2
dimer
VapBC2
dimer
VapBC2
dimer
Figure 2. Three orthogonal views of the VapBC2-DNA complex. (a) VapB2 antitoxins are shown in different tones of blue and VapC2 toxins in
yellow and orange tones. A toxin and antitoxin dimers are labelled using the colours of their components. Two toxin/antitoxin heterodimers are also
marked; in one of them (bottom left) the antitoxin C0-terminus is ordered whereas in the other one (top right) it is not visible. (b) The DNA is
signiﬁcantly bent. (c) The VapBC2 complex interacts with the concave face of the DNA. In the three views, the pseudo-dyad axis, calculated using
the two toxin homodimers as reference, is shown as a red rod with black caps.
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regard, we note that Glu43 in monomer A is involved in
homodimerization contacts via a hydrogen bond to Arg85
from monomer B.
Structure of the VapB2 antitoxin
The antitoxin VapB2 consists of 78 amino acids. The
secondary structure of each monomer comprises two
beta-hairpins (Figure 3c): b1 (residues 6–9)/b2 (residues
12–15) and b3 (residues 28–33)/b4 (residues 36–41) con-
nected by a loop including a short 310 helix (residues
19–21) and followed by helix a1 (residues 46–55).
Residues 59–78, which form an extended coil, are only
visible in monomers F and G (Figure 3c). The inter-
action with the DNA is mediated by the b-hairpins,
whereas the extended coil mediates the inhibitory inter-
action with VapC2 toxin homodimers (Figure 4b, see
below).
Hence, the VapB2 fold differs from that of FitA (7), the
cognate antitoxin of the VapC2 homologue FitB. A struc-
ture similarity search in the DALI server (38) using the
N0-terminal domain of VapB2 (up to residue Pro41)
yielded two main matches of medium-low statistical sig-
niﬁcance: the antitoxin MazE (12, 41) (PDB: 1MVF, chain
E, Z-score=4.4 and PDB: 1UB4, chain C, Z-score=3.3)
and the DNA binding domain of AbrB (42, 43) (PDB:
2RO4, chain B, Z-score=3.1 and PDB: 1Z0R, chain A,
Z-score=3.0), a B. subtilis transcription-state regulator.
This result is consistent with sequence similarity searches
using BLAST against the UniProt database, which gave
SpoVT/AbrB-like proteins (PFAM: PF04014) as the
closest hits to VapB2. The sequence identity for the
ﬁrst 41 residues of VapB2 is 22% with MazE and 15%
with AbrB.
It is therefore adequate to classify VapB2 in the super-
family of AbrB-like transcription factors, also called
swapped-hairpin b-barrel transcription factors. Proteins
of this superfamily fold as homodimeric b-barrels via
two pairs of interleaved beta-hairpins (17). The only sig-
niﬁcant difference with other members of this family with
known structures is that, in VapB2, the two b-hairpins are
connected by a loop including a three-residues long 310
helix instead of a (5–7)-residues long a-helix. Notably,
the ﬁrst residue in the 310 helix, Lys19, and the ﬁrst one
after that helix, Arg22, interacts with DNA phosphates
from the minor groove (see below). Structural superpos-
ition of the DNA-binding domains of VapB2, MazE
(PDB: 1UB4) and AbrB (PDB: 2RO4) shows that the
ﬁrst b-hairpin of VapB2 is more similar to that of MazE
than to that of AbrB, which is shorter. The 310 helix
present in VapB2 superposes to the ﬁrst turn of the
short helix present in MazE and AbrB. The rest of the
linker is an extended coil that roughly superposes to
those of MazE and AbrB (Supplementary Figure S1).
The topology of the swapped-hairpin b-barrel in
the VapB2 dimers is b1, b2, b20, b10, b3, b4, b40, b30
(Figure 3c). Dimerization buries a SASA of 1589±15
A ˚ 2 per VapB2 monomer. This extensive dimerization
interface is stabilized by a central hydrophobic core and
by a network of hydrogen bonds, most of them between
main-chain atoms. The interface also includes two salt
bridges, Lys5-Glu27 and Asn9-Arg16.
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Figure 3. Structures of the VapC2 toxin and the VapB2 antitoxin in the VapBC2–DNA complex. (a) VapC2 toxin monomer A is shown as a ribbon
diagram with labelled secondary structure elements. Blue and red circles mark the position of the N0- and C0-termini, respectively. (b) View of the
toxin homodimer, formed by monomers A and B, along is 2-fold axis (black dot). The four acidic residues of their putative active sites are shown as
sticks coloured by element, with carbons in pink. They are labelled in monomer B. Residues involved in dimerization are depicted as sticks with
coloured by element, with carbons in yellow. They are labelled in monomer A. Hydrogen bonds are represented as dashed black lines. The inset gives
a close-up view of the central part of the homodimer. (c) The antitoxin homodimer formed by monomers F and G viewed across the 2-fold axis of its
b-barrel core. Secondary structure elements are labelled on monomer G. Note the asymmetry of the C0-termini with respect to the homodimer 2-fold
axis. Colour codes are as in Figure 2. For simplicity, one-letter codes are used for aminoacid labels.
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sites of the toxins
VapB2 antitoxins interact with VapC2 toxins through two
contiguous sites. In the ﬁrst site (Figure 4a), the VapB2
b3/b4 hairpin, the a1 helix and the loop that connects
these two elements contact helices a2 and a4 from the
VapC2 toxin. All four TA heterodimers engage in this
type of interaction, which buries a total area of
1739±256A ˚ 2 (941±125A ˚ 2 from VapB2 and 798±132
A ˚ 2 from VapC2). These contacts are essentially driven by
van der Waals forces resulting from the interaction of the
antitoxin a1 helix with a pocket deﬁned by the toxin a2
and a4 helices, as well as by the C0-terminus of its a1 helix.
Trp46 from the VapB2 antitoxin playing a dominant role,
as it ﬁlls a pocket lined by residues Leu25, Glu26, Ile34,
Phe64, Arg67 and Leu68 from VapC2.
A striking feature of the VapBC2 complex is that a
single antitoxin is able to block the access to the two
putative active sites of each toxin homodimer. This 1:2
inhibition was also found in the MazEF complex (12).
The second VapC2/VapB2 interaction site (Figure 4b)
involves a single antitoxin (monomers F and G) and the
two toxins in a VapC2 dimer (toxin dimers AB and CD,
respectively). It is noteworthy that antitoxin monomers F
and G form one of the two antitoxin homodimers.
Therefore, their interaction with the toxin homodimers
effectively breaks the dyad symmetry of the whole
VapBC2 complex. Residues 59–78 from the antitoxin
mediate this type of interaction, which, contrary to the
previous one, is stabilized by a dense network of polar
contacts involving both main-chain and side-chain
atoms. Especially noteworthy are the electrostatic
contacts established by VapB2 Arg66 with residues
Glu43 and Asp99 from the proximal VapC2 monomer.
Contacts between the inhibitory antitoxins and the
proximal toxin monomers are conserved. Conversely,
contacts with the distal VapC2 monomers vary from one
toxin homodimer to the other. Thus, Tyr76 from VapB2
monomer F establishes a hydrogen bond with Glu43 from
the distal VapC2 monomer A. In turn, obstruction of the
active site of the distal VapC2 monomer D is mainly
assured by Arg74 from VapB2 monomer G, which
contacts Glu43 and Asp99 from the distal toxin. Finally,
in all cases VapB2 residues Ile61, Phe62, Tyr76 and Phe77
engage in van der Waals contacts that anchor the
C0-terminus of the antitoxin to the surface of the toxins.
DNA conformation
DNA duplexes from adjacent asymmetric units are
aligned end-to-end to form a supercoiled helix through
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Figure 4. Antitoxin/toxin interactions. (a) Site 1: interaction between the antitoxin monomer G and its proximal toxin (monomer C). Residues with
the strongest contributions are labelled in yellow and white for the antitoxin and the toxin, respectively. Hydrogen bonds are represented as dashed
black lines. This type of interaction surface is present at all toxin/antitoxin interfaces. (b) Site 2: inhibitory interaction between the antitoxin
monomer F and the toxin homodimer made by monomers A and B. The molecular surface of the toxin dimer is coloured by its electrostatic
potential, at 150mM ionic strength, ranging from  51mV (red) to 51mV (blue) at 298K. Residues from the antitoxin are labelled in yellow.
Hydrogen bonds are represented as black lines. (c) Site 2: a detailed view of the interaction of antitoxin monomer G with its distal toxin (monomer
D, dark blue) in an orientation equivalent to that of panel b. Residues with the strongest contributions are labelled in black and blue (except for
Glu43 in white) for the antitoxin and the toxin, respectively. Hydrogen bonds are represented as dashed black lines. Note the different positions and
interactions of residues Arg74 and Tyr76 from the antitoxin. Colour codes are as in Figure 2. For simplicity, one-letter codes are used for aminoacid
labels.
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overall bend of 36.8 , as calculated by CURVES (44)
(Figure 2b). Bending is maximal in the central part of
the DNA and as a result, the molecule offers a concave
surface to the interaction with the VapBC2 complex
(Figures 2b and 5b).
The most remarkable feature of structure of this DNA
is that the minor groove in the AT-rich central region
(bases 13–16, forward chain) is severely compressed,
shrinking to less than half the width of canonical
B-DNA: 2.6A ˚ for base-pairs A13/T15 and A14/T14,
compared to the standard 6A ˚ . In contrast, the minor
groove width increases to 8.5–8.7A ˚ in the region directly
interacting with VapB2 (bases 3–11 and 18–26, forward
chain). The minor groove is again compressed at the DNA
ends, presumably due to crystal packing forces. The oscil-
lations in the minor groove width correlate with changes
in the width of the major groove. However, all along the
DNA molecule, the major groove is wider than in a ca-
nonical B-DNA (11.5A ˚ ). Thus, in the centre of the
fragment the major groove width is  12.4A ˚ , whereas in
the VapB2-interacting area it increases to  15.5A ˚
(Supplementary Figure S2).
Interaction of the antitoxins VapB2 with DNA
The sequence of the vapBC2 promoter used in this study
includes an imperfect palindrome spanning from base
T2 to base T27 (forward sequence), with half-sequence
TA(A/G)TATATA(C/T)TAA. Within this palindrome,
two regions are directly recognized by the antitoxin homo-
dimers: base-pairs A3/T25 to T12/A16 by the EH VapB2
dimer and base-pairs A17/T11 to G26/A2 by the FG
VapB2 dimer (Figure 5a). Since each of these regions
is recognized by an antitoxin homodimer, it is not
surprising to note that they are also internally nearly pal-
indromic (Figure 2), being A(A/G)TAT their
half-sequence.
Globally, the VapB2 homodimers interact with the con-
cave face of the curved DNA: when looking at the
complex along overall longitudinal axis of the DNA, the
dyad axes of the two antitoxin homodimers make an angle
of  110  (Figure 5b). In the VapB2 homodimers the ﬁrst
b-hairpins from each antitoxin (strands b1 and b2) form
together a saddle-shaped surface that deeply penetrates
the DNA major grove (Figure 5a), providing a strong
hydrophobic base to the interaction. A total 1151±7
A ˚ 2 area is buried by the interaction of each antitoxin
homodimer with a half site, resulting in a solvation
energy gain of  14kcalmol
 1, as estimated by PISA
(34). Two residues, Asn9 and Gln11, make speciﬁc
hydrogen bonds with the DNA bases. The Asn9
residues, which are at the C0-terminus of the b1 strand,
contact the central base-pairs while the Gln11 residues, in
the b1-b2 loop, contact the penultimate base-pairs of the
pseudo-palindromic interacting regions. The Asn9
residues speciﬁcally recognize the O4 positions of the thy-
midines belonging to the central base-pairs. The position
of Asn9 is stabilized by the Arg16 residue from the same
antitoxin, which in turn contacts the DNA backbone, thus
contributing to the opening of the major groove. The role
of Gln11 is particularly interesting since it adjusts to the
adenine/guanine variability within the palindrome recog-
nized by each antitoxin dimer. Indeed, the side-chain
amide group of a glutamine residue interacts equally
well with the N6 of an adenine or with the O6 of a
guanine. Besides these contacts, the main-chain amine
from each Gln11 recognizes the N7 position, common to
adenines and guanines. Finally, residues Lys19, from the
310 helix between strands b2 and b3, and Arg22, in the
loop that follows that helix, further contribute to stabilize
the antitoxin–DNA interaction through electrostatic
contacts with the DNA phosphate backbone. A full map
of the VapB2/DNA contacts is available in Suppl.
Figure 3.
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Figure 5. Antitoxin/DNA interaction. (a) Detail of the tight interaction
of the antitoxin homodimer made by monomers F and G with the
DNA. Antitoxin residues are labelled in black for monomer F and in
white with a black contour for monomer G. DNA bases labels are in
italics. Hydrogen bonds are represented as dashed black lines. (b)
Overall view of the disposition of the antitoxin homodimers (only the
b-barrels are shown) with respect to the DNA. The 2-fold axes of the
antitoxin homodimers are shown as black-capped red rods. Colour
codes are as in Figure 2. For simplicity, one-letter codes are used for
aminoacid labels. (c) Sequence conservation in the swapped-hairpin
b-barrel domain at the DNA interface. The sequence of VapB2 was
aligned with the Pfam representative set of sequences for the PF04014
family using Muscle (58). Conservation was mapped onto the molecular
surface of the VapB2 homodimer FG (residues 1–45) using the identity
histogram model implemented in Chimera (36). Protein residue labels
are as in panel a. A colour key bar shows the colour correspondence
for lower (cyan) to higher (maroon) conservation.
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b-barrel DNA binding domain is consistent with the dif-
ferent roles of the b2–b3 and the b1–b2 loops. Thus,
the DNA backbone binding residues in the b2–b3 loop
are the most conserved at the interface with DNA.
Conversely, residues in the b1–b2 loop region, which
make direct base-speciﬁc residues and so drive the rec-
ognition of a particular sequence, are less conserved
(Figure 5c).
DISCUSSION
A (VapC2)4(VapB2)2 heterohexamer likely constitutes the
toxin-inhibited complex whereas a (VapC2)4(VapB2)4
heterooctamer binds to the locus operator DNA
PIN domains resemble structurally to the T4 RNaseH
(10). In keeping with this observation, the PIN domain
of the eukaryotic exosomal protein Rrp44 displays
endoribonucleolytic activity (11) and VapC toxins from
enteric bacteria speciﬁcally cleave the initiator tRNA
fMet
(4). The three conserved acidic residues of the PIN domain
are clustered at the surface of the protein and superpose
well to part of the active site of the T4 RNaseH, namely
RNaseH residues Asp19, Asp71 and Asp132. In VapC2
these residues correspond to amino acids Asp6, Asp99 and
Glu43, respectively (Figure 3b). In the structure described
in this work Asp6 is mutated to glycine. An Asp!Ala
substitution in the equivalent residue (Asp7) of an
enteric VapC toxin resulted in an inactive enzyme in vivo
(4). We infer that the VapC2 protein in our construct is
also inactive.
A fourth acidic residue is present in PIN domains. Its
position at the sequence level can vary from a protein to
another, as it lies in a region structurally more variable
than the former three residues. Glu120, which sits in a
ﬂexible loop that in other PIN domains folds as a short
helix, is the likely candidate for this fourth acidic residue
in VapC2. Actually, the side chain of Glu120 could only
be fully modelled in monomer A, where it is hydrogen
bound to residues Thr115 and Asn8 from the same
monomer. The larger active site of T4 RNaseH coordinates
two divalent metal cations whereas, in principle, the active
site of PIN domains could bind one. Nevertheless, in line
with other known structures of PIN domain proteins, that
of VapC2 in the VapBC2–DNA complex does not include
any metal cation. The Asp6Gly point mutation present in
our VapC2 construct is a likely explanation for this
absence. Notwithstanding, it is also possible that the en-
zymatic mechanism of VapC2 does not imply metal cofac-
tors, that they may have been displaced by the interaction
with the antitoxin or that the metals are only transiently
bound to the enzyme during the reaction.
Globally, the putative active site of VapC2 resides on a
surface pocket near the dimerization interface of the toxin
homodimer; therefore, both active sites are close to each
other. In fact, they are connected by a groove that spans
the full length of the toxin homodimer. In the structure of
VapBC2 this groove is ﬁlled by one antitoxin C0-terminus.
However, it is clear that a putative RNA substrate would
also ﬁt. Consistent with this hypothesis, the groove
presents an overall positive charge, except for the active
site pockets. Since the rest of the dimer bears a negative
electrostatic potential, the groove could aptly attract a
negatively charged substrate such as an RNA fragment.
Based on the fact that the VapB2 anti-toxin blocks the
access to the putative active and substrate-binding sites
of VapC2, we propose that this mode of interaction cor-
responds to the toxin-inhibited complex.
In the other structurally characterized TA complexes
involving PIN-domain toxins, namely N. gonorrhoeae
FitAB and M. tuberculosis VapBC-5, each toxin active
site is blocked in a topologically similar way, that is, by
occlusion of the active and substrate-binding sites
(Supplementary Figure S4), further supporting our hy-
pothesis that the VapB2/VapC2 interaction that we see
corresponds to the toxin-inhibited complex. In the
FitAB structure, each FitB toxin monomer is blocked by
one FitA antitoxin monomer (7). Yet, in the case of
R. felis VapBC2, a single VapB2 antitoxin monomer
sufﬁces to occlude the two active sites of a VapC2 toxin
homodimer. This situation is reminiscent of the MazEF
complex, where a single monomer of MazE, a swapped-
hairpin b-barrel antitoxin similar to VapB2, interacts
with both monomers of a MazF toxin homodimer (12).
We suggest that this interaction scheme, observed in
complexes with two different types of toxins, might be a
characteristic trait of swapped-hairpin b-barrel DNA-
binding antitoxins. The molecular characterization of
other TA pairs involving swapped-hairpin b-barrel anti-
toxins will be needed to conﬁrm this hypothesis.
Notwithstanding, the signiﬁcance of this ﬁnding can be
better understood in view of our SEC/MALS results,
which shows that VapbC2:VapB2 stoichiometry changes
from 4:2 to 4:4 upon binding to DNA. In the absence of
their cognate DNA, MazE and MazF form a hetero-
hexamer comprising two MazF toxin homodimers and a
MazE antitoxin homodimer (12). A 4:2 stoichiometry had
also been inferred for the ccdAB toxin–antitoxin system
(45). However, in the presence of their target DNA ccdAB
would form oligomeric species with a 1:1 molar ratio
(45,46). Hence, it seems conceivable that, at least
for toxin–antitoxin systems involving swapped-hairpin
b-barrel DNA-binding antitoxins, the complexes
required for toxin inhibition and for transcription self-
repression differ. Thus, our data transposes to R. felis
VapBC2 and, at the same time rationalizes, the model
ﬁrst proposed for the CcdAB system (46) (Figure 5). In
these operons the antitoxin genes are coded upstream the
toxin ones, therefore antitoxins will be likely produced at
higher levels than their cognate toxins. However, the anti-
toxins’ high susceptibility to proteases will compensate
and eventually revert this advantage. While the levels of
toxin and antitoxin are high enough and close to a 1:1
molar ratio, they will form complexes able to repress
their own transcription. At some point, the levels of anti-
toxin may decrease so that such complexes are no longer
favoured but still there are enough antitoxin molecules to
inhibit the more stable toxins. Then, if the coding DNA is
still present, transcription can resume before antitoxin
levels decay so much that toxins can poison the host
cell. Hence, the fact that the toxin-inhibitory and the
3254 Nucleic Acids Research, 2012,Vol.40, No. 7transcriptional repressor complexes bear a different stoi-
chiometry adds a further level of control to the TA system.
DNA sequence and toxin/antitoxin interfaces drive the
recognition of the locus operator by the VapBC2 complex
The recognition of speciﬁc DNA sequences by proteins
depends on two types of readout mechanisms that com-
plement each other to assure speciﬁcity and afﬁnity. The
ﬁrst recognized mechanism is the so-called ‘direct’ or
‘base’ readout that involves the formation of hydrogen
bonds with speciﬁc bases, primarily in the major groove.
A second mechanism was subsequently identiﬁed and
dubbed ‘indirect’ or ‘shape’ readout (47,48). Shape
readout depends on the propensity of a given DNA
sequence to assume a conformation that facilitates its
binding to a particular protein. The nucleotides involved
in shape readout do not need to be in contact with the
protein. Indeed, they are often in linker sequences con-
necting two half-sites that bind to different protein
subunits. Such is the case of the A-tract in the core
region of the sequence recognized by the cancer-associated
human papillomavirus E2 protein (49). We ﬁnd a similar
situation in the AT-rich promoter region recognized by
the VapBC2 complex, which includes a central linker
region that separates the two half-sites contacted by the
antitoxin homodimers. In AT-rich sequences, ApT and
ApA (TpT) base pair steps usually display negative roll
angles that lead to a compression of the minor groove
(50). We do observe negative roll angle values between
bases 12 and 16 in the central region (Supplementary
Figure S2), which result in a severely compressed minor
groove in this region. Conversely, TpA steps act as ‘hinge
steps’ that tend to compress the major groove and provide
a higher deformability that can affect the entropy of
complex formation (51). In the DNA bound to VapBC2,
two TpA steps, T11pA12 and T15pA16, separate the
central, minor-groove-compressed region from the
binding half-sites, which are themselves rich in TpA
steps and therefore more deformable. Compression of
the DNA minor groove is widely found in protein-DNA
recognition, where it can serve other purposes than mod-
ifying the DNA shape. Thus, narrow minor grooves
locally enhance the negative electrostatic potential of
DNA and, in that way, they attract positively charged
amino acids, preferably arginines, into the minor groove
(52,53). In the VapBC2–DNA complex, the amino groups
of two lysines, residues Lys19 from the VapB2 molecules
F and H, do contact the phosphate backbone from the
central minor groove of the target DNA.
We conclude that the central compression of the DNA
minor groove, combined with deformable binding
half-sites, enables the antitoxin to insert into adjacent
major grooves in the concave face of the bent DNA.
This is reminiscent of the binding mechanism by which
the Fis protein selects DNA targets based on the intrinsic
width of the minor groove, using the separation between
helix–turn–helix (HTH) motifs as a ruler (54). However,
the structure that we have solved shows that the VapBC2
complex actively participates in this adaptation process:
the VapBC2 complex is not perfectly 2-fold symmetrical,
showing a 175  rotation, instead of 180 , between the two
toxin homodimers. This slight asymmetry reﬂects the need
of this complex to adapt to the relative positions of the
half-sites and strongly supports the notion that a combin-
ation of DNA and protein properties is needed to
allow their mutual recognition and eventual interaction.
To better understand the source of this asymmetry, we
must consider the fact that a VapBC2 hexameric
complex exists in solution in the absence of DNA.
At least for the CcdAB, Phd/doc and ParDE systems, a
high toxin:antitoxin ratio would lift DNA binding or tran-
scriptional repression (46,55–57). Although we have not
determined this behaviour in the case of VapBC2, it is
plausible that VapBC2 hexamers cannot bind DNA, or
antitoxin
degradation
antitoxin
degradation
toxic
activity
VapB2 VapC2 VapB2 VapC2
Figure 6. Proposed model for the regulation by stoichiometry of the transcription control and toxic activities in the VapBC2 system. Transcription
of the VapBC2 locus results in the production of both heterohexameric (VapB2)2(VapC2)4 and homodimeric (VapB2)2 complexes. These complexes
would cooperatively bind to the locus promoter DNA, down-regulating its transcription in a negative feedback. The higher susceptibility to pro-
teolysis of the antitoxin will result in an excess of (VapB2)2(VapC2)4 hexamers and hence in derepression of the promoter DNA and production of
fresh toxin and antitoxin proteins. However, if the DNA coding the VapBC2 has disappeared, or is otherwise repressed, the depleted antitoxin will
not be replaced. Eventually, further degradation of the antitoxin will allow the toxin dimers to freely degrade their substrates. The C0-termini of the
antitoxins in the (VapB2)2 homodimers are not depicted to denote their presumable high disorder or propensity to proteolysis.
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homodimers. One could then hypothesize that while the
toxin:antitoxin ratio is kept low, VapBC2 heterohexamers
and VapB2 homodimers would coexist. In this scenario,
VapB2 homodimers would bind to the recognition
half-sites of their cognate DNA, from where they could
recruit VapBC2 hexamers to form a fully active repression
complex. The antitoxin hinge region (residues Pro41 to
Asn44) is likely to play a major role in the adaptation of
the VapBC2 full complex to its cognate DNA. Finally,
when the levels of antitoxin dwindle, VapBC2 hexamers
will prevail, bind with lower afﬁnity, or not at all to the
DNA and repression will be lifted, so that the toxin:anti-
toxin ratio can be re-equilibrated (Figure 6).
CONCLUSION
The study of the VapBC2 system has provided new
insights into the mechanisms that underlie toxin inhibition
by antitoxins of the swapped-hairpin b-barrel family.
Furthermore, our combination of biophysical and struc-
tural methods has shed light onto how the different
complexes formed by VapB2 and VapC2, but possibly
also by other toxin/antitoxin pairs, integrate the control
of the toxin activity with their participation in the regula-
tion of their own transcription.
This work represents as well the ﬁrst experimental struc-
ture of a protein from the swapped-hairpin b-barrel family
bound to DNA. The structure essentially conﬁrms
previous models based on the unbound structures of
MazE (41) and AbrB (42), while providing a ﬁrst
detailed view of the contacts involved in DNA binding.
Indeed, the structure underlines the importance of a large
interaction surface that results in a marked widening of
the DNA major groove, which combined with the relative
positioning of the VapB2 antitoxin homodimers in the
context of the complex, possibly enhances the bending
of the DNA. Thus, the mutual adjustments between an
intrinsically bendable DNA and the VapB2/VapC2 inter-
faces, both within the VapBC2 heterohexamer and
between this complex and the DNA-bound VapB2
homodimer, may explain the increased afﬁnity of the
ternary toxin–antitoxin–DNA complex.
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